Through careful review of medical history and current health, they can help determine whether symptoms are part of perimenopause or connected to another condition that needs attention
Any treatment plan involving these agents should include: Regular blood tests (glucose, HbA1c, IGF-1, lipids, liver function, renal function) Documented informed consent regarding off-label or investigational use Dietitian input to monitor nutritional status, particularly during periods of rapid weight loss or reduced appetite Reconciliation of all concomitant medicines , including over-the-counter products and supplements, to minimise interaction risks Clear escalation pathways if side effects arise, including urgent review for severe abdominal pain, dehydration, or hypoglycaemia Ongoing review by a named responsible clinician Reporting of any suspected adverse effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) Your health and safety are best protected by working transparently within the NHS or a regulated private medical setting, with full disclosure of all medicines prescribed or otherwise that you are taking
New England Journal of Medicine, 368: 1575-1584 Zhu W, et al
This report highlights the importance of correctly diagnosing BP etiology for guiding precise treatment
Kim 1 , M
Gerstberger S, Jiang Q, Ganesh K
